Showing 1 - 20 results of 73 for search '"Omicron variant"', query time: 0.07s Refine Results
  1. 1

    The Single-Nucleotide Polymorphism (SNP) Validity to Detect Omicron Variants by Lia Gardenia Partakusuma, Luhung Budiailmiawan, null Budiman, Ida Parwati, null Aryati, Basti Andriyoko, Louisa Markus, Corine Niswara, Cut Nur Cinthia Alamanda

    Published 2023-01-01
    “…This study aims to determine the validity of the SNP method with PCR to detect omicron variants of SARS-CoV-2 compared with the gold standard, WGS. …”
    Get full text
    Article
  2. 2
  3. 3

    Antiviral Drugs and Vaccines for Omicron Variant: A Focused Review by Nidhi Garg, Ananya Sree Kunamneni, Pankaj Garg, Sandeep Sharma, Divakar Sharma, Adinarayana Kunamneni

    Published 2023-01-01
    “…The Omicron variant of concern (VOC) replaced the delta variant rapidly and became the predominant strain due to more mutations in spike protein and receptor-binding domain (RBD) enhancing its infectivity and binding affinity. …”
    Get full text
    Article
  4. 4
  5. 5

    Household transmission of SARS-CoV-2 in five US jurisdictions: Comparison of Delta and Omicron variants. by Julia M Baker, Jasmine Y Nakayama, Michelle O'Hegarty, Andrea McGowan, Richard A Teran, Stephen M Bart, Lynn E Sosa, Jessica Brockmeyer, Kayla English, Katie Mosack, Sanjib Bhattacharyya, Manjeet Khubbar, Nicole R Yerkes, Brooke Campos, Alina Paegle, John McGee, Robert Herrera, Marcia Pearlowitz, Thelonious W Williams, Hannah L Kirking, Jacqueline E Tate

    Published 2025-01-01
    “…This investigation aimed to estimate differences in household transmission risk comparing the SARS-CoV-2 Delta and Omicron variants using data from contact tracing and interviews conducted from November 2021 through February 2022 in five U.S. public health jurisdictions (City of Chicago, Illinois; State of Connecticut; City of Milwaukee, Wisconsin; State of Maryland; and State of Utah). …”
    Get full text
    Article
  6. 6

    A Small Surge in Incidence of SARS-CoV-2 Omicron Variant in the “Dynamic Zero” Period by Xiaona Li, Ruili Li, Qiguo Lian, Yang Wang, Wenkui Gu, Qinghe Meng

    Published 2023-01-01
    “…To describe the epidemiological characteristics and transmission dynamics of SARS-CoV-2 Omicron variant during “Dynamic Zero” period, we analyzed data on the 108 laboratory-confirmed SARS-CoV-2 cases during 14 to 30 May 2022 in Beichen district, Tianjin, China. …”
    Get full text
    Article
  7. 7

    Comparison of Clinical Characteristics and Mortality Outcome in Critical COVID-19 Patients Infected with Alpha and Omicron Variants by Cheng HI, Chang KW, Wu BC, Teo MY, Hung WS, Wu HM, Huang ACC, Lin CW, Lin TY, Lin HC, Chiu CH, Lin SM

    Published 2025-01-01
    “…Road, Taipei, Taiwan, Tel + (886) 3-328 1200 ext. 8467, Email smlin100@gmail.comObjective: Early reports have indicated that the Omicron variant of coronavirus disease 2019 (COVID-19) may be associated with low mortality. …”
    Get full text
    Article
  8. 8
  9. 9
  10. 10

    Airborne Transmission of the SARS-CoV-2 Delta Variant and the SARS-CoV-2 Omicron Variant by Byung Uk Lee

    Published 2021-12-01
    “…In addition, if the novel SARS-CoV-2 Omicron variant satisfies the fundamental conditions for universal principles of rapidly spreading respiratory viruses, the airborne transmission of the SARS-CoV-2 Omicron variant needs to be considered.…”
    Get full text
    Article
  11. 11

    COVID-19 Vaccine Booster Dose Fails to Enhance Antibody Response to Omicron Variant in Reinfected Healthcare Workers by Leire Fernández-Ciriza, Álvaro González, José Luis del Pozo, Alejandro Fernandez-Montero, Francisco Carmona-Torre, Paula Martínez de Aguirre, María del Mar Sarasa, Silvia Carlos, Gabriel Reina

    Published 2025-01-01
    “…After the booster dose, participants primoinfected with the Omicron variant exhibited higher antibody concentrations than those who experienced reinfection, even after 6 months of follow-up (22,545 and 9460 U/mL, respectively). …”
    Get full text
    Article
  12. 12

    The omicron variant of SARS-CoV-2 drove broadly increased seroprevalence in a public university setting. by Ching-Wen Hou, Stacy Williams, Guillermo Trivino-Soto, Veronica Boyle, David Rainford, Selina Vicino, Mitch Magee, Yunro Chung, Joshua LaBaer, Vel Murugan

    Published 2025-01-01
    “…The near doubling of anti-NC reactivity, a proxy for history of infection, reflects the contagiousness of the omicron variant, but may also have been influenced by a more relaxed approach to precautions in the spring of 2022. …”
    Get full text
    Article
  13. 13
  14. 14
  15. 15

    Real-world cost-effectiveness of nirmatrelvir-ritonavir as treatment for SARS-CoV-2 infection in the Belgian setting with omicron variant by Sophie Marbaix, Sophie Marbaix, Steven Simoens, Philippe Clevenbergh, Pascal Van Bleyenbergh, Keliane Liberman, Dimitri Dehenau

    Published 2025-02-01
    “…Outcomes were expressed in Quality Adjusted-Life Years (QALYs), hospitalizations, Intensive Care Unit (ICU) admissions, deaths and Long Covid cases, derived from epidemiological data over the first full year of the Omicron variant’s circulation (2022). Costs were calculated for the year 2023 from the healthcare payer’s perspective. …”
    Get full text
    Article
  16. 16
  17. 17
  18. 18

    Anti-SARS-CoV-2 serology based on ancestral RBD antigens does not correlate with the presence of neutralizing antibodies against Omicron variants by Léa Dépéry, Isabelle Bally, Axelle Amen, Benjamin Némoz, Marlyse Buisson, Laurence Grossi, Aurélie Truffot, Raphaële Germi, Delphine Guilligay, Mélanie Veloso, Antoine Vilotitch, Olivier Epaulard, Patrice Morand, Winfried Weissenhorn, Pascal Poignard, Julien Lupo

    Published 2025-01-01
    “…Serological tests based on receptor-binding domain antigens from the ancestral virus fail to predict neutralizing activity against the latest circulating Omicron variants. Adapting serological tests may improve their clinical utility in immunocompromised patients.IMPORTANCEAnti-SARS-CoV-2 serology was developed in 2020 in response to the COVID-19 pandemic to diagnose SARS-CoV-2 infection and monitor an individual’s immunity following natural infection or vaccination. …”
    Get full text
    Article
  19. 19
  20. 20